• 제목/요약/키워드: seoul

검색결과 90,866건 처리시간 0.09초

A Novel Regulatory Role for Liver X Receptors in Adipogenesis

  • Seo, Jong-Bae;Moon, Hyang-Mi;Kim, Woo-Sik;Lee, Yun-Seok;Yoo, Eung-Jae;Park, Jiyoung;Jeong, Hyun-Woo;Kim, Jae-Bum
    • 한국동물학회:학술대회논문집
    • /
    • 한국동물학회 2003년도 한국생물과학협회 학술발표대회
    • /
    • pp.172.2-172
    • /
    • 2003
  • No Abstract, See Full Text

  • PDF

Modification of Prototype D-D Neutron Generator

  • Kim, In-Jung;Kim, Suk-Kwon;Park, Chang-Su;Jung, Nam-Suk;Jung, Hwa-Dong;Park, Ji-Young;Hwang, Yong-Seok;Choi, H.D.
    • 한국원자력학회:학술대회논문집
    • /
    • 한국원자력학회 2005년도 추계학술발표회
    • /
    • pp.818-819
    • /
    • 2005
  • PDF

Femoral fracture in 32 cases;A retrospective study

  • Jang, Byung-Jun;Lim, Ji-Hey;Byeon, Ye-Eun;Jung, Chang-Su;Ryu, Hak-Hyun;Uhm, Ji-Young;Kim, Wan-Hee;Kweon, Oh-Kyeong
    • 한국임상수의학회:학술대회논문집
    • /
    • 한국임상수의학회 2006년도 추계학술대회 및 정기총회
    • /
    • pp.98-98
    • /
    • 2006
  • PDF

Flavonoid glycosides and coumarins from Euodia danielli

  • Yoo, Sang-Woo;Kim, Ju-Sun;Kang, Sam-Sik;Son, Kun-Ho;Kim, Hyun-Pyo;Chang, Hyeun-Wook;Bae, Ki-Hwan;Lee, Chong-Ock
    • 대한약학회:학술대회논문집
    • /
    • 대한약학회 2002년도 Proceedings of the Convention of the Pharmaceutical Society of Korea Vol.1
    • /
    • pp.194.2-194.2
    • /
    • 2002
  • PDF

Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease

  • Ju, Hee Young;Kang, Hyoung Jin;Hong, Che Ry;Lee, Ji Won;Kim, Hyery;Song, Sang Hoon;Yu, Kyung-Sang;Jang, In-Jin;Park, June Dong;Park, Kyung Duk;Shin, Hee Young;Kim, Joong-Gon;Ahn, Hyo Seop
    • Clinical and Experimental Pediatrics
    • /
    • 제59권sup1호
    • /
    • pp.57-59
    • /
    • 2016
  • Chronic granulomatous disease (CGD) is a primary immunodeficiency disease caused by impaired phagocytic function. Hematopoietic stem cell transplantation (HSCT) is a definitive cure for CGD; however, the use of HSCT is limited because of associated problems, including transplantation-related mortality and engraftment failure. We report a case of a patient with CGD who underwent successful HSCT following a targeted busulfan and fludarabine reduced-toxicity myeloablative conditioning. Intravenous busulfan was administered once daily for 4 consecutive days (days -8 to -5), and the target area under the curve was $75,000{\mu}g{\cdot}hr/L$. Fludarabine ($40mg/m^2$) was administered once daily for 6 consecutive days from days -8 to -3. Antithymocyte globulin (2.5 mg/kg/day) was administered from days -4 to -2. The patient underwent successful engraftment and did not have any severe toxicity related to the transplantation. Conditioning with a targeted busulfan and fludarabine regimen could provide a better outcome for HSCT in CGD, with close regulation of the busulfan dose.